Poor Ovarian Responders Undergoing IVF Using Luteal Ovarian Stimulation Versus Follicular Ovarian… (NCT03238833) | Clinical Trial Compass
CompletedNot Applicable
Poor Ovarian Responders Undergoing IVF Using Luteal Ovarian Stimulation Versus Follicular Ovarian Stimulation
Taiwan96 participantsStarted 2017-05-03
Plain-language summary
The investigators attempted to compare the clinical outcomes and cumulus genes expression in poor ovarian responders undergoing luteal ovarian stimulation or follicular ovarian stimulation in in vitro fertilization cycles.
Who can participate
Age range
30 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. advanced maternal age (≥ 40 years) or any other risk factor for POR,
. a previous POR (≤ 3 oocytes with a conventional stimulation protocol), and
. an abnormal ovarian reserve test. An abnormal ovarian reserve test was defined as antral follicle count (AFC) \< 5 or anti-Müllerian hormone (AMH) \< 1 ng/mL in this study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial compared luteal-phase stimulation versus follicular-phase stimulation for poor ovarian responders doing IVF — given my own ovarian reserve results, which of these two stimulation approaches might be more appropriate for my situation?
2Since this trial is completed, has the data been published, and can you share what the results showed about the number of eggs and embryos retrieved with each protocol?
3This trial was specifically for 'poor ovarian responders' — do my test results, like my AMH level or antral follicle count, actually put me in that category before we consider anything from this research?
4Because this study is listed as Phase NA, meaning it wasn't a standard drug-approval trial, what does that mean for how confident we can be about the safety and effectiveness of switching my stimulation timing based on these findings?
5If the luteal stimulation protocol from this trial seems promising for my case, how would it change the timing and logistics of my IVF cycle compared to a standard follicular-phase approach?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
oocytes and embryos
Timeframe: through study completion, an average of 1 year